Back
iShares LifePath Target Date 2060 ETF Vs. Nutex Health, Inc. Industry Stock Comparison
Sell
36
ITDH
iShares LifePath Target Date 2060 ETF
Last Price:
$37.41
Seasonality Move:
1.38%
Sell
41
NUTX
Nutex Health, Inc.
Last Price:
$101.03
Seasonality Move:
-20.28%
Sell
36
iShares LifePath Target Date 2060 ETF (ITDH)
is a Sell
Is iShares LifePath Target Date 2060 ETF a Buy, Sell or Hold?
-
The current iShares LifePath Target Date 2060 ETF [ITDH] share price is $37.33. The Score for ITDH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
ITDH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Nutex Health, Inc. (NUTX)
is a Sell
Is Nutex Health, Inc. a Buy, Sell or Hold?
-
The current Nutex Health, Inc. [NUTX] share price is $100.92. The Score for NUTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NUTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITDH Stock Price Chart
What is iShares LifePath Target Date 2060 ETF's stock price today?
-
The iShares LifePath Target Date 2060 ETF share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUTX Stock Price Chart
What is Nutex Health, Inc.'s stock price today?
-
The Nutex Health, Inc. share price today is $100.92The current trend is relatively stagnant and NUTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITDH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.69 | Buy |
| Relative Strength Index (14 RSI): | 47.74 | Sell |
| Chaikin Money Flow: | 8146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.72 - 38.5) | Sell |
| Bollinger Bands (100): | (37.26 - 38.98) | Sell |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.45 | Sell |
| Relative Strength Index (14 RSI): | 50.67 | Buy |
| Chaikin Money Flow: | 149587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.87 - 105.25) | Buy |
| Bollinger Bands (100): | (98.59 - 163.61) | Sell |
ITDH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.81 | Buy |
| 20-day SMA: | 37.29 | Buy |
| 50-day SMA: | 38.38 | Sell |
| 200-day SMA: | 37.03 | Buy |
| 8-day EMA: | 35.13 | Buy |
| 20-day EMA: | 25.79 | Buy |
| 50-day EMA: | 14.06 | Buy |
| 200-day EMA: | 4.17 | Buy |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.73 | Buy |
| 20-day SMA: | 94.26 | Buy |
| 50-day SMA: | 110.15 | Sell |
| 200-day SMA: | 117.56 | Sell |
| 8-day EMA: | 96.63 | Buy |
| 20-day EMA: | 97.75 | Buy |
| 50-day EMA: | 109.29 | Sell |
| 200-day EMA: | 114.05 | Sell |
iShares LifePath Target Date 2060 ETF Earnings Growth & ITDH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health, Inc. Earnings Growth & NUTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.99 per share, an increase next quarter of $1.49 per share, an increase this year of $16.22 per share, and an increase next year of $0.74 per share.
iShares LifePath Target Date 2060 ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||